differential pricing

Authors from MSF and Harvard School of Public Health have published a critical analysis of the role of tiered pricing to improve access to medicines in developing countries. The study was presented...

In Medical Journals / Research Articles – Last updated 15 November 2011
msfaccess.org/content/win-win-solution-critical-analysis-tiered-pricing-improve-access-medicines-developing

Each year, MSF publishes a survey of the latest prices for antiretroviral medicines to treat people living with HIV/AIDS in developing countries. It started out as a way of offering a practical guide...

Web article – Last updated 08 August 2011
msfaccess.org/content/caught-middle-%E2%80%93-hiv-medicines-pricing-sky-high-%E2%80%98middle-income%E2%80%99-countries

Company price discounts The pharmaceutical industry’s preferred response to the crisis in access to medicines is to establish price discount programmes to combat specific diseases where they offer...

Static page – Last updated 09 August 2011
msfaccess.org/content/overcoming-patent-barriers-through-voluntary-measures

Now in its 12th edition, ‘Untangling the Web of Antiretroviral Price Reductions’ provides a window into the evolution of ARV prices and sheds light on the continuing gaps in treatments needed...

Report – Last updated 21 January 2010
msfaccess.org/content/untangling-web-antiretroviral-price-reductions-12th-edition

Vaccines have made possible some of the greatest public health successes in the past century. Immunisation helps avert an estimated 2.5 million child deaths each year, as well as millions more bouts...

Report – Last updated 10 May 2010
msfaccess.org/content/giving-developing-countries-best-shot-overview-vaccine-access-and-rd

The 12th edition of ‘Untangling the Web’, Médecins Sans Frontières’ annual analysis of antiretroviral (ARV) price reductions is upcoming. This paper serves as a pre-publication...

Report – Last updated 18 July 2009
msfaccess.org/content/untangling-web-antiretroviral-price-reductions-upcoming-12th-edition-pre-publication-price

The data in this guide on ARV prices offered by originator companies and some generic companies in low- and middle-income countries are meant to provide potential buyers with clear and verified data....

Report – Last updated 01 April 2004
msfaccess.org/content/untangling-web-antiretroviral-price-reductions-6th-edition

The aim of this document is to provide information on pricing and suppliers that will help purchasers make informed decisions when buying ARVs. This is the seventh edition of Untangling the web...

Report – Last updated 01 January 2005
msfaccess.org/content/untangling-web-antiretroviral-price-reductions-7th-edition

The purpose of this document is to provide information on prices and suppliers that will help purchasers make informed decisions when buying ARVs.  The report was first published by Médecins...

Report – Last updated 05 September 2006
msfaccess.org/content/untangling-web-antiretroviral-price-reductions-8th-edition

The purpose of this document is to provide information on prices and suppliers that will help purchasers make informed decisions when buying ARVs. However, it is of course important to not only consider...

Report – Last updated 15 July 2008
msfaccess.org/content/untangling-web-antiretroviral-price-reductions-11th-edition-0